Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 ,inter alia, to consider and approve Intimation of Board Meeting under Regulation 29 and 33 of SEBI (LODR) Regulations, 2015 to be held on Thursday, 14th November, 2024, To consider and approve the Un-audited Financial Results of the Company For the Second Quarter and half year ended on 30th September, 2024 ol the current F.Y 2024-25 pursuant to Regulation 33 of the SEBI (LODR) Regulations, 2015.